ArticleJournal of managed care & specialty pharmacy2026

Assessing factor consumption and bleeding outcomes of prophylaxis with 3 commonly prescribed factor IX products for hemophilia B: A retrospective patient medical record analysis in the United States.

Miguel Escobar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.